What is the recommended oral minocycline dose and duration for an otherwise healthy adult with uncomplicated bacterial folliculitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Minocycline Dosing for Bacterial Folliculitis

For uncomplicated bacterial folliculitis in otherwise healthy adults, minocycline 100 mg orally twice daily for 7-14 days is the recommended regimen, based on established guidelines for skin and soft tissue infections including MRSA-associated folliculitis. 1, 2

Standard Dosing Regimen

  • The standard adult dose is 100 mg orally twice daily (every 12 hours), with treatment duration of 7-14 days depending on clinical response. 1, 2

  • A loading dose of 200 mg orally once, followed by 100 mg every 12 hours, is an alternative approach supported by guidelines for skin and soft tissue infections. 1

  • Treatment duration should be at least 7 days to avoid inadequate therapy, which is a common pitfall in managing skin infections. 2

Clinical Context and Rationale

  • Minocycline is effective for methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections, which commonly cause persistent folliculitis. 2

  • The Infectious Diseases Society of America recommends minocycline as an effective alternative to vancomycin or linezolid for outpatient management of MRSA-associated skin infections. 2

  • Minocycline achieves high concentrations in the pilosebaceous complex due to its lipophilicity, making it particularly suitable for follicular infections. 3

Pediatric Dosing (if applicable)

  • For children ≥8 years old weighing <45 kg: 4 mg/kg loading dose (maximum 200 mg), then 2 mg/kg every 12 hours (maximum 100 mg/dose). 1, 2

  • For children ≥8 years old weighing ≥45 kg: Use adult dosing of 100 mg twice daily. 1, 2

  • Minocycline is absolutely contraindicated in children <8 years due to risk of permanent tooth discoloration and enamel hypoplasia. 1, 2

Critical Safety Considerations

  • Vestibular symptoms (dizziness, vertigo, ataxia) occur more frequently with minocycline than other tetracyclines and may affect up to 90% of patients in some contexts. 1

  • Gastrointestinal side effects including nausea, vomiting, and diarrhea are common. 1

  • Pigmentation changes (skin, mucous membranes, teeth) typically occur with cumulative doses >70 grams, which is relevant for prolonged therapy beyond the typical 7-14 day course for folliculitis. 1, 4

  • Photosensitivity is common—patients should avoid direct sun exposure or use appropriate sun protection. 2

Important Contraindications

  • Pregnancy (Category D): Absolutely contraindicated due to fetal harm, tooth discoloration, and skeletal development effects. 1, 2

  • Breastfeeding: Contraindicated as minocycline is distributed into breast milk. 1, 2

  • Children <8 years: Contraindicated due to permanent tooth discoloration risk. 1, 2

  • Hypersensitivity to tetracyclines. 1

Drug Interactions to Avoid

  • Do not administer with antacids containing aluminum, calcium, or magnesium, as these significantly reduce absorption. 1, 2

  • Use caution with oral anticoagulants due to potential interaction. 1, 2

  • May reduce effectiveness of hormonal contraceptives—advise patients to use backup contraception. 2

  • Avoid concurrent use with isotretinoin, methoxyflurane, and penicillins. 1, 2

Special Clinical Scenarios

  • For renal impairment: Doxycycline is preferred over minocycline, but if minocycline is used, monitor plasma urea concentration closely. 1

  • For hepatic impairment: Use with caution and consider baseline and periodic liver function tests for prolonged therapy. 1, 2

  • Gram-negative folliculitis: If bacterial folliculitis fails to improve after 3-6 months of tetracycline therapy, consider gram-negative folliculitis, which is best treated with isotretinoin rather than continued minocycline. 5

Monitoring Requirements

  • For the typical 7-14 day course for uncomplicated folliculitis, routine laboratory monitoring is generally not required. 1

  • For prolonged therapy beyond 2 months, the American Academy of Dermatology recommends complete blood count weekly for the first 2 months, then monthly if stable. 2

  • Baseline and periodic liver function tests are recommended for long-term therapy. 1, 2

Common Pitfalls to Avoid

  • Inadequate treatment duration (<7 days) is a common error—ensure at least 7 days of therapy for bacterial folliculitis. 2

  • Do not use minocycline as monotherapy for acne-related folliculitis—it should be combined with topical benzoyl peroxide and/or retinoids. 1, 3

  • Do not continue minocycline indefinitely without reassessment—if no improvement after 7-14 days, consider alternative diagnoses including gram-negative folliculitis or fungal infection. 5

References

Guideline

Minocycline Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Minocycline Indications and Dosages

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Minocycline in the treatment of acne: latest findings.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2010

Research

Safety of long-term high-dose minocycline in the treatment of acne.

The British journal of dermatology, 1996

Research

Treatment of gram-negative folliculitis in patients with acne.

American journal of clinical dermatology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.